Outpatient Parenteral Antimicrobial Therapy

Jason E. Bowling; James S. Lewis; Aaron D. Owens

doi:10.1016/j.ehmc.2012.07.002

Outpatient Parenteral Antimicrobial Therapy

Jason E. Bowling, James S. Lewis, Aaron D. Owens

Department of Medicine

Research output: Contribution to journal › Review article › peer-review

2 Scopus citations

Abstract

Outpatient parenteral antimicrobial therapy (OPAT) began in the 1970s in the United States. It is estimated that 1 in 1000 Americans receives OPAT each year. OPAT should only be considered in select patients. There are minimal data on using OPAT in patients with substance abuse. A patient's home setting should be assessed before discharge. Consider obtaining written consent from the patient or caregiver before discharging on OPAT. Communication is a key component for an OPAT team. Only certain antimicrobials are candidates for continuous infusion at home. Tracking outcomes with OPAT is important to validate safety and efficacy of care provided.

Original language	English (US)
Pages (from-to)	e45-e56
Journal	Hospital Medicine Clinics
Volume	2
Issue number	1
DOIs	https://doi.org/10.1016/j.ehmc.2012.07.002
State	Published - Jan 2013

Keywords

Adverse events
Antibiotics
Endocarditis
Osteomyelitis
Outpatient parenteral antimicrobial therapy

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/j.ehmc.2012.07.002

Cite this

@article{88b34208e7ff43439e8367693612b293,

title = "Outpatient Parenteral Antimicrobial Therapy",

abstract = "Outpatient parenteral antimicrobial therapy (OPAT) began in the 1970s in the United States. It is estimated that 1 in 1000 Americans receives OPAT each year. OPAT should only be considered in select patients. There are minimal data on using OPAT in patients with substance abuse. A patient's home setting should be assessed before discharge. Consider obtaining written consent from the patient or caregiver before discharging on OPAT. Communication is a key component for an OPAT team. Only certain antimicrobials are candidates for continuous infusion at home. Tracking outcomes with OPAT is important to validate safety and efficacy of care provided.",

keywords = "Adverse events, Antibiotics, Endocarditis, Osteomyelitis, Outpatient parenteral antimicrobial therapy",

author = "Bowling, {Jason E.} and Lewis, {James S.} and Owens, {Aaron D.}",

year = "2013",

month = jan,

doi = "10.1016/j.ehmc.2012.07.002",

language = "English (US)",

volume = "2",

pages = "e45--e56",

journal = "Hospital Medicine Clinics",

issn = "2211-5943",

publisher = "Elsevier Saunders",

number = "1",

}

TY - JOUR

T1 - Outpatient Parenteral Antimicrobial Therapy

AU - Bowling, Jason E.

AU - Lewis, James S.

AU - Owens, Aaron D.

PY - 2013/1

Y1 - 2013/1

N2 - Outpatient parenteral antimicrobial therapy (OPAT) began in the 1970s in the United States. It is estimated that 1 in 1000 Americans receives OPAT each year. OPAT should only be considered in select patients. There are minimal data on using OPAT in patients with substance abuse. A patient's home setting should be assessed before discharge. Consider obtaining written consent from the patient or caregiver before discharging on OPAT. Communication is a key component for an OPAT team. Only certain antimicrobials are candidates for continuous infusion at home. Tracking outcomes with OPAT is important to validate safety and efficacy of care provided.

AB - Outpatient parenteral antimicrobial therapy (OPAT) began in the 1970s in the United States. It is estimated that 1 in 1000 Americans receives OPAT each year. OPAT should only be considered in select patients. There are minimal data on using OPAT in patients with substance abuse. A patient's home setting should be assessed before discharge. Consider obtaining written consent from the patient or caregiver before discharging on OPAT. Communication is a key component for an OPAT team. Only certain antimicrobials are candidates for continuous infusion at home. Tracking outcomes with OPAT is important to validate safety and efficacy of care provided.

KW - Adverse events

KW - Antibiotics

KW - Endocarditis

KW - Osteomyelitis

KW - Outpatient parenteral antimicrobial therapy

UR - http://www.scopus.com/inward/record.url?scp=84870558266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870558266&partnerID=8YFLogxK

U2 - 10.1016/j.ehmc.2012.07.002

DO - 10.1016/j.ehmc.2012.07.002

M3 - Review article

AN - SCOPUS:84870558266

SN - 2211-5943

VL - 2

SP - e45-e56

JO - Hospital Medicine Clinics

JF - Hospital Medicine Clinics

IS - 1

ER -

Outpatient Parenteral Antimicrobial Therapy

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this